MX2017013403A - Transdermal patch hybrid system, coupled with biodegradable microneedles for the administration of pharmaceutical compounds. - Google Patents

Transdermal patch hybrid system, coupled with biodegradable microneedles for the administration of pharmaceutical compounds.

Info

Publication number
MX2017013403A
MX2017013403A MX2017013403A MX2017013403A MX2017013403A MX 2017013403 A MX2017013403 A MX 2017013403A MX 2017013403 A MX2017013403 A MX 2017013403A MX 2017013403 A MX2017013403 A MX 2017013403A MX 2017013403 A MX2017013403 A MX 2017013403A
Authority
MX
Mexico
Prior art keywords
transdermal patch
polymer
administration
coupled
hybrid system
Prior art date
Application number
MX2017013403A
Other languages
Spanish (es)
Inventor
Juan Escobar Chávez José
Serrano Castañeda Pablo
TORRES AGUADO Abraham
Original Assignee
Univ Mexico Nac Autonoma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mexico Nac Autonoma filed Critical Univ Mexico Nac Autonoma
Priority to MX2017013403A priority Critical patent/MX2017013403A/en
Publication of MX2017013403A publication Critical patent/MX2017013403A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present disclosure is related to a transdermal patch hybrid system, coupled with biodegradable microneedles for the administration of pharmaceutical compounds; where the matrix of the transdermal patch comprises: a first polymer to modify the release of the drug; a second polymer with plasticizing, bioadhesive, biocompatible properties, being or not, able to be water-soluble, but being necessarily biocompatible with the first polymer. At least one plasticizer that, in addition to improving the physical and mechanical properties of the transdermal patch, contributes to the release of the drug or drugs combinations; and, a solvent for performing the dissolution; and said biodegradable microneedles comprise a polymer to form the matrix which must be biodegradable, biocompatible, non-toxic and with the ability to have enough hardness to generate micropores in the skin of a user or patient, and may or may not be water-soluble.
MX2017013403A 2017-10-18 2017-10-18 Transdermal patch hybrid system, coupled with biodegradable microneedles for the administration of pharmaceutical compounds. MX2017013403A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2017013403A MX2017013403A (en) 2017-10-18 2017-10-18 Transdermal patch hybrid system, coupled with biodegradable microneedles for the administration of pharmaceutical compounds.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2017013403A MX2017013403A (en) 2017-10-18 2017-10-18 Transdermal patch hybrid system, coupled with biodegradable microneedles for the administration of pharmaceutical compounds.

Publications (1)

Publication Number Publication Date
MX2017013403A true MX2017013403A (en) 2019-04-19

Family

ID=66823389

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017013403A MX2017013403A (en) 2017-10-18 2017-10-18 Transdermal patch hybrid system, coupled with biodegradable microneedles for the administration of pharmaceutical compounds.

Country Status (1)

Country Link
MX (1) MX2017013403A (en)

Similar Documents

Publication Publication Date Title
MX2017012321A (en) Microneedle patch for delivering an active ingredient to skin.
NZ727975A (en) Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa
EP4218724A3 (en) Microstructure array for delivery of active agents
MX2015012433A (en) Microstructure array for delivery of active agents.
CY1122304T1 (en) LOW RAPID RELEASE POLY-(GALACTIDE/GLYCOLIDE) AND METHODS FOR THE PRODUCTION OF POLYMERS
MX2021004546A (en) Implantable drug delivery compositions and methods of use thereof.
MX2018001499A (en) Liquid polymer delivery system for extended administration of drugs.
MX2022006681A (en) Donepezil transdermal delivery system.
CY1120283T1 (en) INTERDERATIVE THERAPEUTIC SYSTEM FOR THE ADMINISTRATION OF RIVASTIGMIN OR ITS PRODUCERS
PH12017501222A1 (en) Glucagon derivatives with improved stability
CY1114975T1 (en) POLYPERIDONIC INFECTION PREPARATION
AR064078A1 (en) SYSTEM OF ADMINISTRATION OF BIOCOMPATIBLE INJECTABLE INTRAOCULAR PHARMACOS, ITS USE TO PREPARE A MEDICINAL PRODUCT AND PROCESS FOR PREPARATION
ES2362525B8 (en) Medication formulation in the form of penetrating percutaneous needles.
NZ733130A (en) Sunitinib formulations and methods for use thereof in treatment of ocular disorders
NZ740615A (en) A pharmaceutical composition comprising electrohydrodynamically obtained fibres, the composition having improved residence time on the application site
MX359119B (en) Sustained release formulations for delivery of proteins to the eye and methods of preparing same.
AR103981A1 (en) METHODS AND COMPOSITIONS PARTICULARLY FOR THE TREATMENT OF THE DISORDER FOR DIFFICULT OF CARE
PH12017501527A1 (en) Oral hemostatic and wound-protective film
Takeuchi et al. Design of rapidly disintegrating drug delivery films for oral doses with hydoxypropyl methylcellulose
MX2016001607A (en) Entecavir microspheres and pharmaceutical composition for parenteral administration containing same.
WO2016040814A3 (en) Disulfide polymers and methods of use
SG10201800072YA (en) Microneedle Patches Comprising Corticosteroid
NZ727834A (en) Fast acting orally disintegrating film
WO2014075203A8 (en) Nanoparticles with biodegradable and biocompatible polymer plga, loaded with the drug for human use pentoxifylline
MD20180043A2 (en) Method for producing hyaluronidase conjugate with polyethylenepiperazine derivatives and the use of the conjugate produced